Gionco David

Chief Accounting Officer at STEMLINE THERAPEUTICS INC; Chief Accounting Officer at SAVIENT PHARMACEUTICALS INC

Sold, on record
$1.5M
Dollars the filings state
Form 4 sales
26
Latest Apr 1, 2020
Form 144 notices
0
Proposed sales
Companies
2
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale STEMLINE THERAPEUTICS INCPlan not stated
    Feb 25, 2019 2019

    Sold 8,563 shares at $12.03 ($103k)

    Gionco David, Chief Accounting Officer

    Sold 3.4% of holdings ($3M position)240,341 shares left1.6x usual sizeFiling

  2. 2 Form 4 sale STEMLINE THERAPEUTICS INCPlan not stated
    Mar 7, 2019 +10 days

    Sold 1,381 shares at $11.32 ($16k)

    Gionco David, Chief Accounting Officer

    Sold 0.6% of holdings ($2.7M position)238,960 shares left0.2x usual sizeFiling

  3. 3 Form 4 sale STEMLINE THERAPEUTICS INCPlan not stated
    Mar 12, 2019 +5 days

    Sold 14,022 shares at $11.11 ($156k)

    Gionco David, Chief Accounting Officer

    Sold 5.9% of holdings ($2.7M position)224,938 shares left2.2x usual sizeFiling

  4. 4 Form 4 sale STEMLINE THERAPEUTICS INCPlan not stated
    Dec 27, 2019 +290 days

    Sold 4,517 shares at $10.84 ($49k)

    Gionco David, Chief Accounting Officer

    Sold 1.9% of holdings ($2.6M position)235,421 shares left0.5x usual sizeFiling

  5. 5 Form 4 sale STEMLINE THERAPEUTICS INCPlan not stated
    Feb 25, 2020 +60 days

    Sold 9,147 shares at $6.43 ($59k)

    Gionco David, Chief Accounting Officer

    Sold 2.7% of holdings ($2.2M position)333,591 shares left1.1x usual sizeFiling

  6. 6 Form 4 sale STEMLINE THERAPEUTICS INCPlan not stated
    Mar 10, 2020 +14 days

    Sold 13,857 shares at $4.98 ($69k)

    Gionco David, Chief Accounting Officer

    Sold 4.2% of holdings ($1.7M position)319,734 shares left1.6x usual sizeFiling

  7. 7 Form 4 sale STEMLINE THERAPEUTICS INCPlan not stated
    Mar 16, 2020 +6 days

    Sold 2,849 shares at $3.88 ($11k)

    Gionco David, Chief Accounting Officer

    Sold 0.9% of holdings ($1.2M position)316,885 shares left0.3x usual sizeFiling

  8. 8 Form 4 sale STEMLINE THERAPEUTICS INCPlan not stated
    Apr 1, 2020 +16 days

    Sold 11,524 shares at $4.79 ($55k)

    Gionco David, Chief Accounting Officer

    Sold 3.9% of holdings ($1.4M position)282,878 shares left1.3x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (26)

Form 144 notices and Form 4 sales by Gionco David
Source
Apr 1, 2020Apr 3, 2020STEMLINE THERAPEUTICS INCChief Accounting OfficerForm 4 sale11,524$55k3.9%Plan not statedSEC
Mar 16, 2020Mar 20, 2020STEMLINE THERAPEUTICS INCChief Accounting OfficerForm 4 sale2,849$11k0.9%Plan not statedSEC
Mar 10, 2020Mar 13, 2020STEMLINE THERAPEUTICS INCChief Accounting OfficerForm 4 sale13,857$69k4.2%Plan not statedSEC
Feb 25, 2020Feb 28, 2020STEMLINE THERAPEUTICS INCChief Accounting OfficerForm 4 sale9,147$59k2.7%Plan not statedSEC
Dec 27, 2019Jan 3, 2020STEMLINE THERAPEUTICS INCChief Accounting OfficerForm 4 sale4,517$49k1.9%Plan not statedSEC
Mar 12, 2019Mar 15, 2019STEMLINE THERAPEUTICS INCChief Accounting OfficerForm 4 sale14,022$156k5.9%Plan not statedSEC
Mar 7, 2019Mar 8, 2019STEMLINE THERAPEUTICS INCChief Accounting OfficerForm 4 sale1,381$16k0.6%Plan not statedSEC
Feb 25, 2019Feb 27, 2019STEMLINE THERAPEUTICS INCChief Accounting OfficerForm 4 sale8,563$103k3.4%Plan not statedSEC
Mar 12, 2018Mar 14, 2018STEMLINE THERAPEUTICS INCChief Accounting OfficerForm 4 sale9,183$160k4.8%Plan not statedSEC
Mar 7, 2018Mar 9, 2018STEMLINE THERAPEUTICS INCChief Accounting OfficerForm 4 sale1,413$23k0.9%Plan not statedSEC
Feb 27, 2018Feb 28, 2018STEMLINE THERAPEUTICS INCChief Accounting OfficerForm 4 sale8,984$157k5.5%Plan not statedSEC
Jan 17, 2018Jan 19, 2018STEMLINE THERAPEUTICS INCChief Accounting OfficerForm 4 sale4,250$57k2.5%Plan not statedSEC
Mar 7, 2017Mar 9, 2017STEMLINE THERAPEUTICS INCChief Accounting OfficerForm 4 sale1,116$9k1.2%Plan not statedSEC
Feb 28, 2017Mar 1, 2017STEMLINE THERAPEUTICS INCChief Accounting OfficerForm 4 sale6,486$45k6.3%Plan not statedSEC
Jan 19, 2017Jan 24, 2017STEMLINE THERAPEUTICS INCChief Accounting OfficerForm 4 sale3,593$41k3.4%Plan not statedSEC
Mar 8, 2016Mar 10, 2016STEMLINE THERAPEUTICS INCChief Accounting OfficerForm 4 sale1,148$6k1.1%Plan not statedSEC
Jan 20, 2016Jan 21, 2016STEMLINE THERAPEUTICS INCChief Accounting OfficerForm 4 sale3,217$15k8.4%Plan not statedSEC
Jan 20, 2015Jan 21, 2015STEMLINE THERAPEUTICS INCChief Accounting OfficerForm 4 sale3,311$47k11.0%Plan not statedSEC
Oct 15, 2013Oct 17, 2013SAVIENT PHARMACEUTICALS INCChief Accounting OfficerForm 4 sale47,876$4k57.2%UnusualSEC
Mar 6, 2013Mar 8, 2013SAVIENT PHARMACEUTICALS INCGroup VP & Chief Acct. OfficerForm 4 sale1,560$1k1.8%Plan not statedSEC
Jan 24, 2011Jan 27, 2011SAVIENT PHARMACEUTICALS INCGroup VP & CFOForm 4 sale2,032$20k4.5%Plan not statedSEC
Dec 20, 2010Dec 30, 2010SAVIENT PHARMACEUTICALS INCGroup VP & CFOForm 4 sale1,536$18k3.3%Plan not statedSEC
Feb 16, 2010Feb 17, 2010SAVIENT PHARMACEUTICALS INCGroup VP & CFOForm 4 sale1,253$17k3.9%Plan not statedSEC
Feb 9, 2010Feb 11, 2010SAVIENT PHARMACEUTICALS INCGroup VP & CFOForm 4 sale2,037$26k5.9%Plan not statedSEC
Dec 21, 2009Dec 22, 2009SAVIENT PHARMACEUTICALS INCVP, CFOForm 4 sale1,511$20k4.2%Plan not statedSEC
Sep 15, 2009Sep 15, 2009SAVIENT PHARMACEUTICALS INCGroup VP, CFOForm 4 sale18,387$287k33.9%UnusualSEC